Purpose: Enhance the Quality Use of Medicines (QUM) and reduce adverse medicine events.
Referral and Eligibility
Referring Practitioners:
General Practitioner (GP)
Specialist in Pain Medicine
Specialist Physician
Specialist Psychiatrist
Specialist in Palliative Medicine
Referral Process:
Patients choose to provide the referral to their usual Community Pharmacy or another Service Provider (e.g., sole trader Accredited Pharmacist).
Eligibility Criteria:
Hold a current Medicare card or Department of Veterans’ Affairs (DVA) card.
Live in a community setting.
At risk of or experiencing medication misadventure.
Identifiable clinical need confirmed by the Referring Medical Practitioner.
More than 5 regular meds
More than 12 doses/day
Recent significant change in medication
Meds with narrow therapeutic index/need monitoring
Symptoms suggest adverse reaction
Sub-optimal response to treatment
Suspect non complaince
Difficulty managing because literacy/language
Impaired sight/confusion/dementia/cognitive
Multiple doctors
Recent discharge facility/hospital
Not eligible if currently an in-patient at a hospital, transition care facility, or resident of an Aged Care Facility.
HMR Process
Collaborative Effort:
Involves the Referring Medical Practitioner, GP (if not the Referrer), Accredited Pharmacist, Patient, healthcare team members, and where appropriate, a carer.
Initial Interview:
Conducted by an Accredited Pharmacist to improve the Patient’s understanding of their medicines.
HMR Report:
Produced by the Accredited Pharmacist after the initial Interview.
Outlines findings and recommendations.
Aims to assist the Referrer and Patient in developing a medication management plan.
Provided to the Referrer, GP (if not the Referrer), and any other healthcare team members as requested by the patient.
Should be uploaded to the Patient’s My Health Record (if available).
Follow-Up Services
Follow-Up Interviews:
Up to two follow-ups can be conducted if clinically indicated.
First follow-up: No earlier than one month and no later than nine months after the initial Interview.
Second follow-up: No earlier than one month after the first follow-up and no later than nine months after the initial Interview.
Indications for Follow-Up:
Determined during the initial HMR Report based on medication-related problems identified.
Participation and Registration
Service Providers:
S90 Community Pharmacies and entities with an Accredited Pharmacist relationship can register.
Must meet eligibility requirements and agree to the Pharmacy Programs Administrator General Terms and Conditions.
Register on the Pharmacy Programs Administrator Portal.
Funding:
HMR Services under the 7CPA must be provided at no charge to the Patient if they meet eligibility criteria.
If ineligible or non-consenting to data sharing for claims, the service can be offered at the Patient’s cost.